Pulmonary & Respiratory Medicine

ISSN: 2161-105X

Open Access

Airway-Centered Granulomatous Fibrinous and Organizing Pneumonia as a Manifestation of Sirolimus-A Reversible Pulmonary Toxicity


Andrews Arthur, Sriaroon Chakrapol, Rumbak Mark, Prendes Barbara, Johnson Jean, Leslie Kevin, Matta Amir and Solomon David

Sirolimus is a potent immunosuppressant medication and is used in renal transplant patients to prevent acute graft rejection. Various pulmonary toxicities in patients treated with sirolimus include cough, desquamative interstitial pneumonia (DIP), diffuse interstitial pneumonia, diffuse alveolar damage (DAD), diffuse alveolar hemorrhage (DAH), alveolar phospholipoproteinosis and pulmonary hypertension with features of hemolytic uremic syndrome (HUS). We describe a case of a patient with an insidious development of chest X-ray (CXR), computed tomography of the chest (CT chest) and pulmonary function (PFT) (mainly the DLCO) abnormalities. When this progressed, an open lung biopsy was performed revealing granulomatous inflammation consistent with a hypersensitivity reaction. The abnormalities on imaging and pulmonary function testing improved after drug discontinuation. We suggest that patients using this drug have yearly DLCOs as their pulmonary symptoms may be few. If the DLCO declines significantly then a high resolution CT Chest should be performed. If abnormal, biopsy is warranted.


Share this article

Google scholar citation report
Citations: 1242

Pulmonary & Respiratory Medicine received 1242 citations as per google scholar report

Pulmonary & Respiratory Medicine peer review process verified at publons

Indexed In

arrow_upward arrow_upward